Delivery Order 36F79721D0213-36C26123N0701
Award Date
6/29/23
Potential Completion Date
8/29/23
Potential Value
$32K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Hikma Pharmaceuticals USA Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Berkeley Heights, NJ 07922, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product XYREM, awarded to Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals. The contract is a Delivery Order with a Firm Fixed Price of $32,486.80 and an ultimate completion date of September 11, 2023. The contract was awarded on July 11, 2023 by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency under the Department of Veterans Affairs (VA). The contract is not set-aside and is part of...
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Amneal Pharmaceuticals Of New York, LLC (doing business as Amneal Pharmaceuticals) for the supply of XYREM (sodium oxybate) oral solution. The $173,571.00 contract, issued under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs, has an ultimate completion date of October 31, 2025. Amneal, a for-profit limited liability company that manufactures pharmaceuticals and drugs, has also been...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, to provide the specialty medication Xyrem. The $53,357.40 firm fixed price delivery order was placed under Jazz Pharmaceuticals' $150 million Blanket Purchase Agreement and $116 million Federal Supply Schedule contract for the Pharmaceuticals and Drugs product category. The contract supports the VA's provision of healthcare services...
This federal contract award is for the delivery of XYREM SODIUM OXYBATE 500MG/ML SOLN, ORAL 180ML to the U.S. Department of Veterans Affairs (VA). The $83,424.42 firm fixed-price delivery order was awarded to Jazz Pharmaceuticals, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract supports the VA's Veterans Health Administration by providing specialized medications, specifically treatments for sleep disorders and neurological conditions. The award...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a $49,921 firm fixed price blanket purchase agreement call contract to Jazz Pharmaceuticals, Inc. to supply pharmacy ordering services for XYREM prescriptions. The contract was awarded utilizing Jazz Pharmaceutical's Pharmaceuticals and Drugs GSA Schedule, which allows federal agencies to place orders for pharmaceutical products and related services. Performance will take place in Palo...
This is a federal contract award made by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, for the delivery of the medication XYWAV 500 MG ORAL SOLUTION. The contract is a firm fixed price Delivery Order issued under Jazz Pharmaceuticals' Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with a ceiling value of $10,229.64. The contract has an ultimate completion date of July 31, 2024. No set-aside designation was used. This...
This is a delivery order awarded by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, for the specialty pharmaceutical Xyrem. The $21,714.82 firm fixed price contract was issued under Jazz Pharmaceuticals' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows the VHA to efficiently procure needed medications. This delivery order supports healthcare services for veterans at VHA facilities...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jazz Pharmaceuticals, Inc. for the provision of Xyrem medication to the Durham VA Medical Center Pharmacy. The contract is a firm fixed price type, with a ceiling value of $547,993.80. It was awarded on October 1, 2016 and has an ultimate completion date of December 12, 2017. The contract is placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allowing the VA to...
This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in rare neurological diseases and sleep disorders. The $10,170.00 firm fixed price order is for the drug WAKIX (pitolisant) and is issued against Harmony Biosciences' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract. This award is not...
This is a delivery order awarded by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $10,229.64 firm fixed price order is for the supply of XYWAV 500 MG ORAL SOLUTION to VHA facilities in the St. Louis, MO area through December 2024. No set-asides were used for this award. As a prime contractor on the Pharmaceuticals and Drugs FSS, Jazz Pharmaceuticals provides specialty medications like...